- Home
- NCRA vs RLYB Comparison
NCRA vs RLYB Comparison
Compare NCRA & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- RLYB
- Stock Information
- Founded
- NCRA 2002
- RLYB 2018
- Country
- NCRA Taiwan
- RLYB United States
- Employees
- NCRA N/A
- RLYB N/A
- Industry
- NCRA Farming/Seeds/Milling
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- RLYB Health Care
- Exchange
- NCRA Nasdaq
- RLYB Nasdaq
- Market Cap
- NCRA 21.4M
- RLYB 24.1M
- IPO Year
- NCRA N/A
- RLYB 2021
- Fundamental
- Price
- NCRA $1.68
- RLYB $0.53
- Analyst Decision
- NCRA
- RLYB Hold
- Analyst Count
- NCRA 0
- RLYB 2
- Target Price
- NCRA N/A
- RLYB N/A
- AVG Volume (30 Days)
- NCRA 21.4K
- RLYB 332.8K
- Earning Date
- NCRA 11-13-2025
- RLYB 11-06-2025
- Dividend Yield
- NCRA N/A
- RLYB N/A
- EPS Growth
- NCRA N/A
- RLYB N/A
- EPS
- NCRA N/A
- RLYB N/A
- Revenue
- NCRA $13,865,984.00
- RLYB $761,000.00
- Revenue This Year
- NCRA N/A
- RLYB N/A
- Revenue Next Year
- NCRA N/A
- RLYB N/A
- P/E Ratio
- NCRA N/A
- RLYB N/A
- Revenue Growth
- NCRA N/A
- RLYB 154.51
- 52 Week Low
- NCRA $0.70
- RLYB $0.22
- 52 Week High
- NCRA $2.09
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- NCRA 58.30
- RLYB 45.61
- Support Level
- NCRA $1.54
- RLYB $0.48
- Resistance Level
- NCRA $1.75
- RLYB $0.60
- Average True Range (ATR)
- NCRA 0.11
- RLYB 0.04
- MACD
- NCRA 0.02
- RLYB -0.01
- Stochastic Oscillator
- NCRA 87.27
- RLYB 35.88
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.